Alignment Healthcare, Inc. $ALHC Shares Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. boosted its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 6,708.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,774,975 shares of the company’s stock after acquiring an additional 1,748,903 shares during the period. Assenagon Asset Management S.A. owned 0.89% of Alignment Healthcare worth $35,056,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. Larson Financial Group LLC acquired a new position in Alignment Healthcare in the third quarter worth about $33,000. GAMMA Investing LLC raised its stake in Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after buying an additional 987 shares in the last quarter. KBC Group NV acquired a new stake in Alignment Healthcare during the second quarter valued at approximately $44,000. Wilmington Savings Fund Society FSB bought a new position in Alignment Healthcare during the 3rd quarter worth approximately $53,000. Finally, PNC Financial Services Group Inc. grew its position in shares of Alignment Healthcare by 205.6% in the 3rd quarter. PNC Financial Services Group Inc. now owns 3,459 shares of the company’s stock worth $60,000 after acquiring an additional 2,327 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO John E. Kao sold 605,648 shares of the company’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $11,349,843.52. Following the completion of the transaction, the chief executive officer owned 2,234,294 shares in the company, valued at approximately $41,870,669.56. This represents a 21.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Dawn Christine Maroney sold 282,070 shares of the stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80. Following the completion of the sale, the president directly owned 1,385,167 shares in the company, valued at approximately $25,958,029.58. This trade represents a 16.92% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 2,418,393 shares of company stock valued at $46,473,667. 7.00% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ALHC has been the subject of a number of research analyst reports. Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, March 7th. Robert W. Baird set a $28.00 price objective on Alignment Healthcare in a research note on Friday, January 30th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. UBS Group boosted their target price on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, January 14th. Finally, JPMorgan Chase & Co. increased their target price on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.56.

Alignment Healthcare Stock Up 0.9%

NASDAQ:ALHC opened at $17.58 on Thursday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.80. The stock has a 50 day moving average of $20.21 and a 200-day moving average of $18.83. The firm has a market capitalization of $3.59 billion, a PE ratio of -1,756.24, a price-to-earnings-growth ratio of 2.55 and a beta of 1.18. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.10. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The business’s revenue was up 44.4% on a year-over-year basis. During the same quarter last year, the business posted ($0.16) EPS. Analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.